EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
February 28, 2005
Primary Completion Date
September 30, 2005
Conditions
Primary Peritoneal Cavity CancerStage I Endometrial CarcinomaStage I Ovarian Epithelial CancerStage IA Cervical CancerStage IB Cervical CancerStage II Endometrial CarcinomaStage II Ovarian Epithelial CancerStage IIA Cervical CancerStage IIB Cervical CancerStage III Cervical CancerStage III Endometrial CarcinomaStage III Ovarian Epithelial CancerStage IV Endometrial CarcinomaStage IV Ovarian Epithelial CancerStage IVA Cervical CancerStage IVB Cervical Cancer
Interventions
DRUG
EF5
Given IV
Trial Locations (1)
19104
Abramson Cancer Center of The University of Pennsylvania, Philadelphia
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00107445 - EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer | Biotech Hunter | Biotech Hunter